Calcitriol (RO215535) - Moligand™, 10mM in DMSO , Agonist of Vitamin D receptor, CAS No.32222-06-3, Agonist of Vitamin D receptor

CAS: 32222-06-3 Cat. No.: C409109 Peso molecular: 416.64 Beilstein Registry Number: 7559394 Número EC: 250-963-8
Disponible para pedir
GRADE & PURITY Moligand™ ? Moligand™ — Aladdin's line of ligands and bioactive small molecules. Use for receptor, pathway, and binding studies needing defined small-molecule tools. 10mM in DMSO
Synonyms
Topitriol, 1,25-Dihydroxyvitamin D3 | (1R,3S,Z)-5-((E)-2-((1R,3aS,7aR)-1-((R)-6-hydroxy-6-methylheptan-2-yl)-7a-methyl-octahydroinden-4-ylidene)ethylidene)-4-methylenecyclohexane-1,3-diol
Storage
Store at -80°C
Shipped In
Dry ice packs + Cold packs
 ·  off list, applied to all prices below.
Size
Estado
Price
Qty
1ml
C409109-1ml
1

399,90US$

466,90US$
Guardar 67,00 US$ (14.35%)
Enter a quantity for the sizes you want to add.
🧪

Why this grade

Moligand™, 10mM in DMSO Moligand™ for sensitive chromatographic and analytical workflows requiring minimal baseline interference.

🌡

Storage & shipping

Store at -80°C Ships Dry ice packs + Cold packs Check lot-specific COA for exact specifications.

📋

Quality documents

SDS, COA, datasheet, and spec sheet available for download. Lot-specific COA accessible via lot number lookup.

📚

Literature proof

Cited in 23 peer-reviewed publications across chromatography, organic synthesis, and cross-coupling reactions.

Descripción general

Information

Calcitriol (RO215535, Topitriol, 1,25-Dihydroxyvitamin D3) is a nonselectivevitamin D receptoractivator/agonist(VDRA), exhibiting a 10-fold higher vitamin D receptor (VDR) binding affinity(IC50=0.4 nM) than the selective VDRA paricalcitol.Solutions are be
In vitro

Calcitriol is a potent inhibitor of PHA-induced lymphocyte proliferation, achieving 70% inhibition of tritiated thymidine incorporation after 72 h in culture. Calcitriol suppresses interleukin-2 (IL-2) production by PHA-stimulated peripheral blood mononuclear cells in a concentration-dependent fashion. Calcitriol increases the concentration of intracellular calcium ([Ca2+]i) within 5 s by mobilizing calcium from the endoplasmic reticulum and the formation of inositol 1,4, 5-trisphosphate and diacylglycerol. Calcitriol can inhibit the proliferation and promote the differentiation of human prostate adenocarcinoma cells. Calcitriol causes a selective decrease in the secreted levels of type IV collagenases (MMP-2 and MMP-9). Calcitriol has antiproliferative activity in squamous cell carcinoma and prostatic adenocarcinoma and enhances the antitumor activity of platinum-based agents. Calcitriol prior to paclitaxel significantly reduces clonogenic survival compared with either agent alone in the murine squamous cell carcinoma and PC-3 cells. Calcitriol is a potent anti-proliferative agent in a wide variety of malignant cell types. Calcitriol effects are associated with an increase in G0/G1 arrest, induction of apoptosis and differentiation, modulation of expression of growth factor receptors. Calcitriol potentiates the antitumor effects of many cytotoxic agents and inhibits motility and invasiveness of tumor cells and formation of new blood vessels.

In vivo


Cell Data

cell lines:U87MG, LNCaP and PC3 cells

Concentrations:

Incubation Time:

Powder Purity:≥99%

Specifications

Sinónimos
Topitriol, 1, 25-Dihydroxyvitamin D3 | (1R, 3S, Z)-5-((E)-2-((1R, 3aS, 7aR)-1-((R)-6-hydroxy-6-methylheptan-2-yl)-7a-methyl-octahydroinden-4-ylidene)ethylidene)-4-methylenecyclohexane-1, 3-diol
Especificaciones y pureza
Moligand™, 10mM in DMSO
Mecanismos bioquímicos y fisiológicos
Calcitriol (RO215535, Topitriol, 1, 25-Dihydroxyvitamin D3) is a nonselective vitamin D receptor activator/agonist(VDRA), exhibiting a 10-fold higher vitamin D receptor (VDR) binding affinity(IC50=0.4 nM) than the selective VDRA paricalcitol.
Condiciones de almacenamiento de almacenamiento
Store at -80°C
Enviado en
Dry ice packs + Cold packs
Este producto requiere envío en cadena de frío. Los servicios terrestres y otros servicios económicos no están disponibles.
Grado
Moligand™
Tipo de acción
AGONIST
Mecanismo de acción
Agonist of Vitamin D receptor
Propiedades del producto
ALogP5.1
Nombres e identificadores
Isómeros SMILES C[C@H](CCCC(C)(C)O)[C@H]1CC[C@@H]\2[C@@]1(CCC/C2=C\C=C/3\C[C@H](C[C@@H](C3=C)O)O)C
WGK Alemania 3
RTECS FZ4645000
Peso molecular 416.64
Beilstein 7559394
Reaxy-Rn 30827300
Reaxys-RN_link_address https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN=30827300&ln=

Documentation

📋 Safety Data Sheet (SDS)

Comprehensive hazard, handling, storage, and regulatory compliance document.

Download SDS →

✅ Certificate of Analysis (COA)

Lot-specific quality data. Enter your lot number to retrieve the exact COA.

Look up COA →

📊 Datasheet

Quick-reference summary of product specifications and applications.

View datasheet →

🔬 Specification Sheet

Full quality attributes and acceptance criteria for this grade.

View spec sheet →

Advanced Data

Objetivos asociados (humanos)
VDR Tclin Vitamin D3 receptor (48 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
GC Tchem Vitamin D-binding protein (1 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
Certificados (CoA, COO, BSE/TSE y tabla de análisis)
C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:
Propiedades químicas y físicas
Punto de fusión (°C)119°C(lit.)
Preguntas frecuentes y artículos
Citations of This Product
Referencias
1. Chen An, Lan Zirong, Li Li, Xie Luting, Liu Xiaoyu, Yang Xiulin, Wang Siyi, Liang Qingchun, Dong Qianqian, Feng Liyun, Li Yining, Ye Yuanzhi, Fu Mingwei, Lu Lihe, Yan Jianyun.  (2023)  SGLT2 inhibitor canagliflozin alleviates vascular calcification through suppression of NLRP3 inflammasome.  CARDIOVASCULAR RESEARCH,      [PMID:37523743] [10.1093/cvr/cvad119]
2. Pingcui Xu, Bingfeng Lin, Xuehui Deng, Kai Huang, Yan Zhang, Nani Wang.  (2022)  VDR activation attenuates osteoblastic ferroptosis and senescence by stimulating the Nrf2/GPX4 pathway in age-related osteoporosis.  FREE RADICAL BIOLOGY AND MEDICINE,      [PMID:36402439] [10.1016/j.freeradbiomed.2022.11.013]
3. Zhengtian Lyu, Haifang Li, Xin Li, Hui Wang, Hongchao Jiao, Xiaojuan Wang, Jingpeng Zhao, Hai Lin.  (2022)  Fibroblast growth factor 23 inhibits osteogenic differentiation and mineralization of chicken bone marrow mesenchymal stem cells.  POULTRY SCIENCE,      [PMID:36442309] [10.1016/j.psj.2022.102287]
4. Chen Xue-qi, Mao Jia-yu, Wang Chun-saier, Li Wen-bin, Han Tao-tao, Lv Ke, Li Jing-nan.  (2022)  CYP24A1 Involvement in Inflammatory Factor Regulation Occurs via the Wnt Signaling Pathway.  Current Medical Science,  42  (5): (1022-1032).  [PMID:36255661] [10.1007/s11596-022-2564-x]
5. Xiaonan Chen, Yiqing Zou, Shuqi Zhang, Pengchao Fang, Shuxuan Li, Pengyu Li, Yingying Sun, Gang Yuan, Haiyan Hu.  (2022)  Multi-functional vesicles improve Helicobacter pylori eradication by a comprehensive strategy based on complex pathological microenvironment.  Acta Pharmaceutica Sinica B,      [PMID:36176916] [10.1016/j.apsb.2022.05.014]
6. Yongzhi Cui, Yuanyuan Guo, Li Kong, Jingyu Shi, Ping Liu, Rui Li, Yongtao Geng, Weihang Gao, Zhiping Zhang, Dehao Fu.  (2021)  A bone-targeted engineered exosome platform delivering siRNA to treat osteoporosis.  Bioactive Materials,      [PMID:34901540] [10.1016/j.bioactmat.2021.09.015]
7. Huiling Chen, Kaiqiang Hu, Yaru Liang, Yuqi Gao, Chenye Zeng, Kang Xu, Xiaojin Shi, Liyuan Li, Yuemiao Yin, Yi Qiao, Ying Qiu, Qingfei Liu, Zhao Wang.  (2021)  Ample dietary fat reduced the risk of primary vesical calculi by inducing macrophages to engulf budding crystals in mice.  Acta Pharmaceutica Sinica B,      [PMID:35256944] [10.1016/j.apsb.2021.08.001]
8. Zehua Li, Ji Wu, Xiuli Zhang, Caiwen Ou, Xinglong Zhong, Yanting Chen, Lihe Lu, Hailin Liu, Yining Li, Xiaoyu Liu, Bo Wu, Yuxi Wang, Pingzhen Yang, Jianyun Yan, Minsheng Chen.  (2019)  CDC42 promotes vascular calcification in chronic kidney disease.  JOURNAL OF PATHOLOGY,  249  (4): (461-471).  [PMID:31397884] [10.1002/path.5334]
9. Hailin Liu, Xiuli Zhang, Xinglong Zhong, Zehua Li, Shaoai Cai, Pingzhen Yang, Caiwen Ou, Minsheng Chen.  (2019)  Puerarin inhibits vascular calcification of uremic rats.  EUROPEAN JOURNAL OF PHARMACOLOGY,      [PMID:31085237] [10.1016/j.ejphar.2019.05.023]
10. Meihui Fan, Guowen Zhang, Junhui Pan, Deming Gong.  (2017)  An inhibition mechanism of dihydromyricetin on tyrosinase and the joint effects of vitamins B6, D3 or E.  Food & Function,  (7): (2601-2610).  [PMID:28686246] [10.1039/C7FO00236J]
11. Wang Sikai, Cheng Hongxia, Li Miaomiao, Gao Dongmei, Wu Haoran, Zhang Shanshan, Huang Yilan, Guo Kun.  (2024)  BNIP3-mediated mitophagy boosts the competitive growth of Lenvatinib-resistant cells via energy metabolism reprogramming in HCC.  Cell Death & Disease,  15  (7): (1-18).  [PMID:38969639] [10.1038/s41419-024-06870-9]
12. Jiale Mao, Houxing Lei, Pingcui Xu, Shuang Liu, Jiwang Zhou, Mingrong Mei, Nani Wang, Xiaoqin Zhang.  (2024)  Identifying key components from Melastoma dodecandrum in TNF-α-induced osteoblast injury model through a combination of cell membrane chromatography and mass spectrometry.  JOURNAL OF ETHNOPHARMACOLOGY,      [PMID:39326812] [10.1016/j.jep.2024.118836]
13. Xiaoqin Zhang, Jiale Mao, Lu Shao, Shuang Liu, Jiwang Zhou, Mingrong Mei, Zunjing Zhang.  (2024)  Screening of active components of melastoma dodecandrum lour. against diabetic osteoporosis using cell membrane chromatography-mass spectrometry.  Frontiers in Pharmacology,      [PMID:39525628] [10.3389/fphar.2024.1450154]
14. Fang Liu, Qingchun Liang, Li Li, Yuan Gong, Mingxi Li, Liyun Feng, An Chen, Yuanzhi Ye, Zirong Lan, Yining Li, Jing-Song Ou, Lihe Lu, Jianyun Yan.  (2025)  Thrombospondin-1 binds to integrin β3 to inhibit vascular calcification through suppression of NF-κB pathway.  JOURNAL OF PATHOLOGY,      [PMID:40084742] [10.1002/path.6417]
15. Xuemin Xian, Xin Zhao, Xingchen Zhou, Hanfang Liu, Changxi Li, Xinquan Wu, Yuhang Chen, Keyue Ye, Hongwei Yang, Mingxi Li, Jianyun Yan, Xiuli Zhang.  (2025)  Honokiol attenuates oxidative stress and vascular calcification via the upregulation of heme oxygenase-1 in chronic kidney disease.  TOXICOLOGY AND APPLIED PHARMACOLOGY,      [PMID:40194744] [10.1016/j.taap.2025.117318]
16. Zhenyu Zhu, Hao Liu, Liyun Feng, Lihe Lu, Jiahui Zhu, Qingchun Liang, Zirong Lan, Yuanzhi Ye, Siyi Wang, An Chen, Jianyun Yan.  (2025)  Loss of ADAMTS5 promotes vascular calcification via versican/integrin β1/FAK signal.  ATHEROSCLEROSIS,      [PMID:40215897] [10.1016/j.atherosclerosis.2025.119190]
17. Zhu Mengyao, Ren Lu, Xiao Wenlong, Wang Longjian, Hu Zhiming, Wang Nani.  (2025)  Senkyunolide I suppresses hepatic stellate cell activation and liver fibrosis by reprogramming VDR-dependent fatty acid metabolism.  Chinese Medicine,  20  (1): (1-17).  [PMID:40514735] [10.1186/s13020-025-01133-x]
18. Shangheng Fan, Youbo Yu, Yunqin Wei, Jing An, Qi Wang, Yan Yang.  (2025)  Targeting the mTOR-mitochondrial function axis: Calcitriol attenuates sarcopenic obesity with lipid dysregulation etiology.  FREE RADICAL BIOLOGY AND MEDICINE,      [PMID:41173312] [10.1016/j.freeradbiomed.2025.10.282]
19. Ding Liu, Yuanzhi Ye, Zirong Lan, An Chen, Xingchen Zhou, Zhenhao Li, Xin Wen, Jisheng Xiao, Fan Ouyang, Jianyun Yan.  (2025)  Ultrasmall Cu2−xSe nanoparticles alleviate vascular calcification through inhibiting oxidative stress and NF-κB/NLRP3-mediated inflammation.  Redox Biology,      [PMID:41353801] [10.1016/j.redox.2025.103961]
20. Ruman Chen, Jiqing He, Na An, Mingzhi Xu, Liheng Wang, Yafei Bai.  (2026)  MiR-181c-5p-SIRT1 axis-driven Pink1/Parkin-mediated mitophagy prevents ferroptosis and vascular calcification in chronic kidney disease.  EXPERIMENTAL CELL RESEARCH,      [PMID:41512994] [10.1016/j.yexcr.2025.114875]
21. Chengsi Li, Jing Li, Chengyingjie Yang, Zhenghao Zhu, Yachen Zhang, Yin Xiang.  (2026)  Vericiguat improves CKD-related vascular calcification through the NO/cGMP/PKG pathway.  INTERNATIONAL IMMUNOPHARMACOLOGY,      [PMID:41723893] [10.1016/j.intimp.2026.116413]
22. Guangxiao Zhang, Yawen Sun, Ling He, Bowen Zhao, Hongchao Jiao, Jingpeng Zhao, Xiaojuan Wang, Min Liu, Kelin Li, Hai Lin, Haifang Li.  (2026)  In ovo injection of vitamin D3 improves intestinal development of chicks via activating vitamin D receptor.  POULTRY SCIENCE,  105  (5): (106672).  [PMID:41723960] [10.1016/j.psj.2026.106672]
23. Zi Lin Li, Gang Wang, Yilin Ding, Qiyuan Dai, Huitong Luo, Zhifeng Shi, Xinrong Xu, Xiaodong Cao.  (2026)  High performance injectable PLLA/BG composite microspheres in aging skin regeneration.  Biomaterials Advances,      [PMID:] [10.1016/j.bioadv.2026.214823]
Calculadoras de soluciones
Reseñas

Reseñas de cliente

Need help choosing the grade?

Our grade selection guide covers purity, stabilizer status, and application suitability for all variants in our catalog.

View Moligand™ grade guide →

Shall we send you a message when we have discounts available?

Remind me later

Thank you! Please check your email inbox to confirm.

Oops! Notifications are disabled.